Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Krogsgaard

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Annals of Clinical and Translational Neurology|September 27, 2022
Hybrid and vaccine-induced immunity against SAR-CoV-2 in MS patients on different disease-modifying therapiesIlya Kister, Ryan Curtin, Jinglan Pei, et al.
Annals of Neurology|March 15, 2022
Cellular and Humoral Immunity to SARS-CoV-2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease-Modifying Therapies: A Multi-Ethnic Observational StudyIlya Kister, Yury Patskovsky, Ryan Curtin, et al.
Journal of Translational Medicine|July 28, 2023
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy)Paolo A Ascierto, Sanjiv S Agarwala, Allison Betof Warner, et al.
Cancer Discovery|February 3, 2026
A targetable developmental program co-regulates angiogenesis and immune evasion in melanomaPietro Berico, Amanda Flores Yanke, Fatemeh Vand-Rajabpour, et al.
Journal of Translational Medicine|July 1, 2021
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy)Paolo A Ascierto, Christian Blank, Reinhard Dummer, et al.
Journal of Translational Medicine|September 4, 2022
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy)Paolo A Ascierto, Sanjiv S Agarwala, Christian Blank, et al.
Nature Medicine|June 5, 2025
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanomaKelsey R Monson, Robert Ferguson, Joanna E Handzlik, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Annals of Clinical and Translational Neurology|September 27, 2022
Hybrid and vaccine-induced immunity against SAR-CoV-2 in MS patients on different disease-modifying therapiesIlya Kister, Ryan Curtin, Jinglan Pei, et al.
Annals of Neurology|March 15, 2022
Cellular and Humoral Immunity to SARS-CoV-2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease-Modifying Therapies: A Multi-Ethnic Observational StudyIlya Kister, Yury Patskovsky, Ryan Curtin, et al.
Journal of Translational Medicine|July 28, 2023
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy)Paolo A Ascierto, Sanjiv S Agarwala, Allison Betof Warner, et al.
Cancer Discovery|February 3, 2026
A targetable developmental program co-regulates angiogenesis and immune evasion in melanomaPietro Berico, Amanda Flores Yanke, Fatemeh Vand-Rajabpour, et al.
Journal of Translational Medicine|July 1, 2021
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy)Paolo A Ascierto, Christian Blank, Reinhard Dummer, et al.
Journal of Translational Medicine|September 4, 2022
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy)Paolo A Ascierto, Sanjiv S Agarwala, Christian Blank, et al.
Nature Medicine|June 5, 2025
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanomaKelsey R Monson, Robert Ferguson, Joanna E Handzlik, et al.
Pageof 7